RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Summary

This phase I trial is studying the side effects of RO4929097 before surgery in treating patients with pancreatic cancer. RO4929097 may stop the growth of tumor cells by blocking some enzymes needed for cell growth. Giving RO4929097 before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

Timeline

Start

2010-08

Primary completion

2012-01

Completion

—

Drugs

Indications